Pharmacokinetic-pharmacodynamic guided trial design in oncology: Role of modeling and simulation in clinical development of anticancer agents
Gespeichert in:
| Veröffentlicht in: | Investigational new drugs 2003, Vol.21 (2), p.225-241 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 241 |
|---|---|
| container_issue | 2 |
| container_start_page | 225 |
| container_title | Investigational new drugs |
| container_volume | 21 |
| creator | VAN KESTEREN, Ch MATHOT, R. A. A BEIJNEN, J. H SCHELLENS, J. H. M |
| description | |
| format | Article |
| fullrecord | <record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_15000267</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15000267</sourcerecordid><originalsourceid>FETCH-pascalfrancis_primary_150002673</originalsourceid><addsrcrecordid>eNqNjbsKwjAUQIMoWB__kMUxkNo2oZODKI4O7uWSpPVqXiR16N_r0A9wOhw4cBakKBtZMS5qsSQFL4Vkom3lmmxyfnHOq1bWBTndn5AcqPBGb0ZULM6uJw8OFR0-qI2mY0KwVJuMg6foafAq2DBMO7LqwWazn7klh-vlcb6xCFmB7RN4hbmLCR2kqSub3_koZPVv9wVdYDy4</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Pharmacokinetic-pharmacodynamic guided trial design in oncology: Role of modeling and simulation in clinical development of anticancer agents</title><source>SpringerLink Journals - AutoHoldings</source><creator>VAN KESTEREN, Ch ; MATHOT, R. A. A ; BEIJNEN, J. H ; SCHELLENS, J. H. M</creator><creatorcontrib>VAN KESTEREN, Ch ; MATHOT, R. A. A ; BEIJNEN, J. H ; SCHELLENS, J. H. M</creatorcontrib><identifier>ISSN: 0167-6997</identifier><identifier>EISSN: 1573-0646</identifier><identifier>CODEN: INNDDK</identifier><language>eng</language><publisher>Dordrecht: Kluwer</publisher><subject>Biological and medical sciences ; General pharmacology ; Medical sciences ; Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions ; Pharmacology. Drug treatments</subject><ispartof>Investigational new drugs, 2003, Vol.21 (2), p.225-241</ispartof><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15000267$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>VAN KESTEREN, Ch</creatorcontrib><creatorcontrib>MATHOT, R. A. A</creatorcontrib><creatorcontrib>BEIJNEN, J. H</creatorcontrib><creatorcontrib>SCHELLENS, J. H. M</creatorcontrib><title>Pharmacokinetic-pharmacodynamic guided trial design in oncology: Role of modeling and simulation in clinical development of anticancer agents</title><title>Investigational new drugs</title><subject>Biological and medical sciences</subject><subject>General pharmacology</subject><subject>Medical sciences</subject><subject>Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions</subject><subject>Pharmacology. Drug treatments</subject><issn>0167-6997</issn><issn>1573-0646</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNqNjbsKwjAUQIMoWB__kMUxkNo2oZODKI4O7uWSpPVqXiR16N_r0A9wOhw4cBakKBtZMS5qsSQFL4Vkom3lmmxyfnHOq1bWBTndn5AcqPBGb0ZULM6uJw8OFR0-qI2mY0KwVJuMg6foafAq2DBMO7LqwWazn7klh-vlcb6xCFmB7RN4hbmLCR2kqSub3_koZPVv9wVdYDy4</recordid><startdate>2003</startdate><enddate>2003</enddate><creator>VAN KESTEREN, Ch</creator><creator>MATHOT, R. A. A</creator><creator>BEIJNEN, J. H</creator><creator>SCHELLENS, J. H. M</creator><general>Kluwer</general><scope>IQODW</scope></search><sort><creationdate>2003</creationdate><title>Pharmacokinetic-pharmacodynamic guided trial design in oncology</title><author>VAN KESTEREN, Ch ; MATHOT, R. A. A ; BEIJNEN, J. H ; SCHELLENS, J. H. M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pascalfrancis_primary_150002673</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Biological and medical sciences</topic><topic>General pharmacology</topic><topic>Medical sciences</topic><topic>Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>VAN KESTEREN, Ch</creatorcontrib><creatorcontrib>MATHOT, R. A. A</creatorcontrib><creatorcontrib>BEIJNEN, J. H</creatorcontrib><creatorcontrib>SCHELLENS, J. H. M</creatorcontrib><collection>Pascal-Francis</collection><jtitle>Investigational new drugs</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>VAN KESTEREN, Ch</au><au>MATHOT, R. A. A</au><au>BEIJNEN, J. H</au><au>SCHELLENS, J. H. M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacokinetic-pharmacodynamic guided trial design in oncology: Role of modeling and simulation in clinical development of anticancer agents</atitle><jtitle>Investigational new drugs</jtitle><date>2003</date><risdate>2003</risdate><volume>21</volume><issue>2</issue><spage>225</spage><epage>241</epage><pages>225-241</pages><issn>0167-6997</issn><eissn>1573-0646</eissn><coden>INNDDK</coden><cop>Dordrecht</cop><pub>Kluwer</pub></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0167-6997 |
| ispartof | Investigational new drugs, 2003, Vol.21 (2), p.225-241 |
| issn | 0167-6997 1573-0646 |
| language | eng |
| recordid | cdi_pascalfrancis_primary_15000267 |
| source | SpringerLink Journals - AutoHoldings |
| subjects | Biological and medical sciences General pharmacology Medical sciences Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions Pharmacology. Drug treatments |
| title | Pharmacokinetic-pharmacodynamic guided trial design in oncology: Role of modeling and simulation in clinical development of anticancer agents |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T20%3A41%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacokinetic-pharmacodynamic%20guided%20trial%20design%20in%20oncology:%20Role%20of%20modeling%20and%20simulation%20in%20clinical%20development%20of%20anticancer%20agents&rft.jtitle=Investigational%20new%20drugs&rft.au=VAN%20KESTEREN,%20Ch&rft.date=2003&rft.volume=21&rft.issue=2&rft.spage=225&rft.epage=241&rft.pages=225-241&rft.issn=0167-6997&rft.eissn=1573-0646&rft.coden=INNDDK&rft_id=info:doi/&rft_dat=%3Cpascalfrancis%3E15000267%3C/pascalfrancis%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |